Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx - Concepedia

Concepedia

Publication | Closed Access

Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx

75

Citations

0

References

2001

Year

H. Bier, Thomas K. Hoffmann, U. Häuser, Michaël Wink, Martin Öchler, Andreas Kovar, Matthias Müser, R. Knecht

Cancer Chemotherapy and Pharmacology

MedicinePathologyHead And Neck CancerCancer TreatmentImmunotherapyOncologyRadiation OncologyCancer ResearchCancer Growth

No additional data available for this publication yet. Check back later!